Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by SSM0006on Jan 03, 2017 1:12pm

24 Views

Post# 25662310

RE:RE:RE:RE:RE:RE:RE:4-6 Months for NHS Industries

Couldn't have said it better!!

here4urcomments wrote: Amen.. How ridiculous. Have faith in your 'veture', or get out and purchase something safe. They are called ventures for a reason. I'm in the red, small holding, but because i only invested money that I could afford to lose, I will sit back and hope that somewhere down the line the company hits their stride and we will prosper. whining and complaining isn't going to work.

Bullboard Posts

Morning Market Outlook for Nov. 14, 2024